Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro

British Journal of Haematology

Volumn 147, Issue 3, 2009, Pages 396-398

  Amrein, Lilian ^a,b   Panasci, Lawrence ^a,b   Gibson, Spencer B ^c   Johnston, James B ^c   Soulières, Denis ^d   Aloyz, Raquel ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Chronic lymphocytic leukaemia; Dasatinib; Del 17; P53

Indexed keywords

ABELSON KINASE; CHLORAMBUCIL; DASATINIB; FLUOROURACIL; PROTEIN P53; PROTEIN TYROSINE KINASE; RITUXIMAB;

CELL DEATH; CELL SURVIVAL; CHROMOSOME DELETION; CHROMOSOME DELETION 17; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME INHIBITION; HUMAN; IC 50; IN VITRO STUDY; LETTER; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 70349915923     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07814.x     Document Type: Letter

References (10)

1. Aloyz, R., Grzywacz, K., Xu, Z.Y., Loignon, M., Alaoui-Jamali, M.A. Panasci, L. (2004) Imatinib sensitizes CLL lymphocytes to chlorambucil. Leukemia, 18, 409 414.
2. Amrein, L., Hernandez, T.A., Ferrario, C., Johnston, J., Gibson, S.B., Panasci, L. Aloyz, R. (2008a) Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro. British Journal of Haematology, 143, 698 706.
3. Amrein, P.C., Attar, E., Takvorian, T., Hochberg, E., Ballen, K.K., Leahy, K.M., Neuberg, D. Brown, J.R. (2008b) Dasatinib Has Activity in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL/SLL), a Phase II Trial. Blood, 112, 1084.
4. Contri, A., Brunati, A.M., Trentin, L., Cabrelle, A., Miorin, M., Cesaro, L., Pinna, L.A., Zambello, R., Semenzato, G. Donella-Deana, A. (2005) Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. Journal of Clinical Investigation, 115, 369 378.
5. Hamblin, T.J. Oscier, D.G. (1997) Chronic lymphocytic leukaemia: the nature of the leukaemic cell. Blood Reviews, 11, 119 128.
6. Pettitt, A.R., Sherrington, P.D., Stewart, G., Cawley, J.C., Taylor, A.M.R. Stankovic, T. (2001) p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood, 98, 814 822.
7. Pitini, V., Arrigo, C. Altavilla, G. (2009) Dasatinib induces a response in chronic lymphocytic leukemia. Blood, 113, 498.
8. Steele, A.J., Prentice, A.G., Hoffbrand, A.V., Yogashangary, B.C., Hart, S.M., Nacheva, E.P., Howard-Reeves, J.D., Duke, V.M., Kottaridis, P.D., Cwynarski, K., Vassilev, L.T. Wickremasinghe, R.G. (2008) p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism. Blood, 112, 3827 3834.
9. Willmore, E., Elliott, S.L., Mainou-Fowler, T., Summerfield, G.P., Jackson, G.H., O'Neill, F., Lowe, C., Carter, A., Harris, R., Pettitt, A.R., Cano-Soumillac, C., Griffin, R.J., Cowell, I.G., Austin, C.A. Durkacz, B.W. (2008) DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia. Clinical Cancer Research, 14, 3984 3992.
10. Zenz, T., Benner, A., Dohner, H. Stilgenbauer, S. (2008) Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway. Cell Cycle, 7, 3810 3814.